Exponent, Inc. (EXPO) Analysts See $0.60 EPS

June 14, 2018 - By Alfred Lee

Exponent, Inc. (NASDAQ:EXPO) LogoInvestors sentiment decreased to 1.31 in Q1 2018. Its down 0.35, from 1.66 in 2017Q4. It worsened, as 14 investors sold Exponent, Inc. shares while 56 reduced holdings. 24 funds opened positions while 68 raised stakes. 22.31 million shares or 0.02% less from 22.32 million shares in 2017Q4 were reported.
Price T Rowe Md holds 0.01% or 525,149 shares in its portfolio. Point72 Asia (Hong Kong) Limited has 23 shares for 0% of their portfolio. Legal & General Public Ltd Com holds 53,727 shares or 0% of its portfolio. Rhumbline Advisers reported 0.01% of its portfolio in Exponent, Inc. (NASDAQ:EXPO). Moreover, Kayne Anderson Rudnick Investment Management Ltd Co has 0.03% invested in Exponent, Inc. (NASDAQ:EXPO) for 55,428 shares. Gsa Prtn Llp stated it has 14,284 shares or 0.06% of all its holdings. Stone Ridge Asset Lc owns 0.03% invested in Exponent, Inc. (NASDAQ:EXPO) for 6,308 shares. Schwab Charles Inv Mgmt has invested 0.01% in Exponent, Inc. (NASDAQ:EXPO). Principal Financial Group Inc stated it has 0.02% in Exponent, Inc. (NASDAQ:EXPO). Parkside Fin National Bank And stated it has 54 shares. Trexquant Inv Ltd Partnership reported 2,794 shares. Louisiana State Employees Retirement Sys holds 11,400 shares or 0.04% of its portfolio. Great West Life Assurance Company Can reported 34,453 shares. Goldman Sachs Gru holds 0% of its portfolio in Exponent, Inc. (NASDAQ:EXPO) for 174,778 shares. Citigroup reported 0% stake.

Since May 7, 2018, it had 0 insider purchases, and 6 selling transactions for $3.78 million activity. Shares for $322,154 were sold by Pye John. Another trade for 2,639 shares valued at $248,161 was made by Kytomaa Harri on Friday, May 18. On Monday, May 7 the insider SCHLENKER RICHARD L JR sold $2.57 million. $48,004 worth of Exponent, Inc. (NASDAQ:EXPO) was sold by Zumwalt Debra on Friday, May 25.

Analysts expect Exponent, Inc. (NASDAQ:EXPO) to report $0.60 EPS on July, 17.They anticipate $0.09 EPS change or 17.65 % from last quarter’s $0.51 EPS. EXPO’s profit would be $15.60M giving it 20.77 P/E if the $0.60 EPS is correct. After having $0.61 EPS previously, Exponent, Inc.’s analysts see -1.64 % EPS growth. The stock increased 1.22% or $0.6 during the last trading session, reaching $49.85. About 226,231 shares traded. Exponent, Inc. (NASDAQ:EXPO) has risen 61.24% since June 14, 2017 and is uptrending. It has outperformed by 48.67% the S&P500.

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting firm worldwide. The company has market cap of $1.30 billion. The Company’s services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation. It has a 32.58 P/E ratio. The firm operates in two divisions, Engineering and Other Scientific, and Environmental and Health.

Exponent, Inc. (NASDAQ:EXPO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.